Literature DB >> 20693631

Is the urea cycle involved in Alzheimer's disease?

Franck Hansmannel1, Adeline Sillaire, M Ilyas Kamboh, Corinne Lendon, Florence Pasquier, Didier Hannequin, Geoffroy Laumet, Anais Mounier, Anne-Marie Ayral, Steven T DeKosky, Jean-Jacques Hauw, Claudine Berr, David Mann, Philippe Amouyel, Dominique Campion, Jean-Charles Lambert.   

Abstract

Since previous observations indicated that the urea cycle may have a role in the Alzheimer's disease (AD) process, we set out to quantify the expression of each gene involved in the urea cycle in control and AD brains and establish whether these genes could be genetic determinants of AD. We first confirmed that all the urea cycle enzyme genes are expressed in the AD brain. The expression of arginase 2 was greater in the AD brain than in the control brain. The presence of the rare arginase 2 allele rs742869 was associated with an increase in the risk of AD in men and with an earlier age-at-onset for both genders. None of the other genes in the pathway appeared to be differentially expressed in the AD brain or act as genetic determinants of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693631      PMCID: PMC2945690          DOI: 10.3233/JAD-2010-100630

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  35 in total

1.  Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions.

Authors:  D J Schaid; S J Jacobsen
Journal:  Am J Epidemiol       Date:  1999-04-15       Impact factor: 4.897

2.  Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain.

Authors:  Tatjana Nilsson; Nenad Bogdanovic; Inga Volkman; Bengt Winblad; Ronnie Folkesson; Eirikur Benedikz
Journal:  Biochem Biophys Res Commun       Date:  2006-04-07       Impact factor: 3.575

3.  Human type II arginase: sequence analysis and tissue-specific expression.

Authors:  S M Morris; D Bhamidipati; D Kepka-Lenhart
Journal:  Gene       Date:  1997-07-09       Impact factor: 3.688

4.  Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons.

Authors:  Alvaro G Estévez; Mary Anne Sahawneh; Philipp S Lange; Narae Bae; Mariela Egea; Rajiv R Ratan
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

Review 5.  Alzheimer's disease a century later.

Authors:  Richard J Caselli; Thomas G Beach; Roy Yaari; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

6.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

7.  Estimation of multiple relative risk functions in matched case-control studies.

Authors:  N E Breslow; N E Day; K T Halvorsen; R L Prentice; C Sabai
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

Review 8.  Molecular genetics of Alzheimer's disease.

Authors:  M Cruts; C Van Broeckhoven
Journal:  Ann Med       Date:  1998-12       Impact factor: 4.709

Review 9.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  25 in total

1.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 2.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

3.  Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants.

Authors:  Burcu F Darst; Qiongshi Lu; Sterling C Johnson; Corinne D Engelman
Journal:  Genet Epidemiol       Date:  2019-05-18       Impact factor: 2.135

Review 4.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

5.  What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease.

Authors:  Mark Mapstone; Feng Lin; Mike A Nalls; Amrita K Cheema; Andrew B Singleton; Massimo S Fiandaca; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2016-11-21       Impact factor: 4.673

6.  Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Authors:  Jericha Mill; Lingjun Li
Journal:  Phenomics       Date:  2022-02-22

Review 7.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Authors:  Saak Victor Ovsepian; Valerie Bríd O'Leary
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

9.  Inhibition of Urea Transporter (UT)-B Modulates LPS-Induced Inflammatory Responses in BV2 Microglia and N2a Neuroblastoma Cells.

Authors:  Aimée C Jones; Farhana Pinki; Gavin S Stewart; Derek A Costello
Journal:  Neurochem Res       Date:  2021-03-06       Impact factor: 3.996

10.  Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.

Authors:  Chao Ma; Jerry B Hunt; Andrii Kovalenko; Huimin Liang; Maj-Linda B Selenica; Michael B Orr; Bei Zhang; John C Gensel; David J Feola; Marcia N Gordon; Dave Morgan; Paula C Bickford; Daniel C Lee
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.